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Peripheral vascular disease (PVD) produces hypoxic con-
ditions in the lower limb that can lead to ulceration and
amputation. Studies of the cutaneous sequelae associated
with this problem are much needed since demographic data
predict a rising number of patients with PVD due to an in-
crease in the geriatric population. In addition, the obesity
epidemic in the US is evoking a rapid escalation in the
number of cases of type II diabetes in an increasingly
younger patient population. Such patient groups will pre-
dictably develop cardiovascular perturbations leading to
hypoxic conditions in the leg and foot region. Break-
throughs in treatment modalities are sorely needed to com-
bat the impact of ulcers and amputations on quality-of-life
issues ranging from financial, social, and psychological im-
plications to matters of morbidity and mortality.
In this issue, Dalton and coworkers have begun to forge a
pathway toward a greater molecular understanding of the
events that lead to skin breakdown when the lower extrem-
ity is afflicted with severe peripheral vascular disease. Their
team recognized that documentation of events/conditions
in ischemic lower extremities is a requisite step that must
precede the design of effective therapeutics to combat non-
healing wounds in this patient population. Their approach is
unique in that they chose not to analyze the wound bed
after the fact. Instead, they analyzed unmistakably hypoxic
skin prior to its ulceration and development into a chronic
wound. Their report provides evidence of abnormal extra-
cellular matrix metabolism in chronically ischemic skin.
They hypothesize that these abnormalities may be causal
factors leading to skin breakdown.
Traditionally, evidence-based medicine in the chronic
wound field has been hampered by the apparent unavail-
ability of tissue samples. Institutional Review Boards have
been loath to approve excisional biopsies in patients who
are at highest risk of developing non-healing wounds that
could easily progress to amputation. Fortunately, Dalton
and associates remained undaunted by problems of sample
collection and patient recruitment. Instead, they devised a
clever plan to retrieve intact hypoxic skin tissues from am-
putated limbs that were previously relegated to the scrap
heap in the biohazard waste. Their report focuses on both
the synthesis and degradation aspects of the equilibrium in
the extracellular matrix (ECM) in chronically ischemic leg
tissues. The result is a foundational analysis of major ECM
dynamics in the skin complete with site-matched controls
compared against normal samples from patients having
knee replacements or elective removal of superficial veins.
Their data derived from chronically hypoxic yet un-
wounded skin augment information in the field of wound
repair. PVD produces an obvious deficiency in oxygen and
other nutrients necessary for tissues to heal and thrive. The
role of oxygen in wound healing has been deemed to be
important for years (Hunt, 2004). Recent articles on this
molecule of interest have suggested that oxygen is more
than just a nutrient (Tandara and Mustoe, 2004). Although
the wide range of oxygen tensions found in tissues makes it
difficult to establish a standardized numerical value to de-
fine hypoxia, scientists are in agreement that hypoxia is
defined as a condition when oxygen delivery does not meet
the metabolic demands of the tissue. As cells sense hypo-
xia, they mount adaptive cellular reactions that lead to mul-
tiple transcriptional as well as post-transcriptional events
(Papandreou et al, 2005). Within the ECM, oxygen is es-
sential at an enzymatic level since prolyl hydroxylase is re-
quired for the hydroxylation of proline, a requisite step if
procollagen molecules are to form stable triple-helical con-
formation in the ECM (Tandara and Mustoe, 2004). Since
hypoxic, normoxic, and hyperoxic conditions are easily re-
produced in the culture dish, much of the current hypoxic-
based literature is derived from such a setting. Chronic
hypoxic conditions in vitro are well known to decrease the
proliferative activities of fibroblasts and to decrease trans-
forming growth factor-b (TGF-b)1 mRNA and its TGF-b re-
ceptor values, and the converse is true under normoxic or
hyperbaric conditions (Mogford et al, 2002, 2004).
Newer molecules such as hypoxia-inducible factor 1
(HIF-1) have also been implicated in acute and chronic
hypoxic settings such as those surveyed by Dalton and
coworkers. HIF-1 is one such nuclear factor that seems to
serve as a prime regulator of gene expression when the
microenvironment becomes hypoxic (Semenza, 1999). Ox-
ygen-dependent regulation of gene expression in culture
and in wounds has also been reported for inducible nitric
oxide synthase, arginase I, vascular endothelial cell growth
factor (VEGF), tumor necrosis factor-a (TNF-a), TGF-b, in-
terleukin (IL)-6, IL-8, cyclooxygenase (COX)-2, among oth-
ers (Albina and Reichner, 2003). Although the acute effects
of hypoxia on cells is known to result in apoptosis or cellular
death, the pathophysiologic impact of a severe oxygen
deficit over a chronic time interval has remained unknown.
Practically, every one of these hypoxic experiments has
been performed within the wound-healing milieu; yet, none
was performed in chronically ischemic tissues BEFORE
development into a non-healing wound. Thus, the natural
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history of hypoxic events in a limb afflicted with PVD has
been largely ignored until now.
From time to time, promising new therapeutic approach-
es for treatment of chronically ischemic skin have appeared
on the horizon. A recent example was the therapeutic an-
giogenesis approach that sought to improve perfusion by
the growth of new blood vessels. Unfortunately, the phase II
randomized, double-blind study with intramuscular adeno-
viral delivery of VEGF in patients with disabling claudication
did not fulfil its expectations and did not show sustained
efficacy in improving even intramuscular blood flow, much
less cutaneous blood flow in the affected limb (Rajagopalan
et al, 2003). A subsequent study using an ischemic hindlimb
model performed a careful immunohistological analysis and
provided a possible explanation by showing that angiogen-
esis was only transient in nature (Gounis et al, 2005). Nev-
ertheless, optimism about future developments remains
high since other creative avenues remain open, and there
remain a host of candidate molecules that may be deficient
or elevated in the chronically ischemic skin setting. Work
with tumor cells and their blood supply has suggested that
hypoxic tissues respond by halting the cell cycle, thereby
blocking the addition of new cells into the tissue and/or by
the induction of programmed cell death or apoptosis (Pa-
pandreou et al, 2005). Whether such mechanisms factor in
the hypoxic circumstances within chronically ischemic skin
tissues in vivo was not directly addressed by Dalton and
colleagues in this issue but should definitely be evaluated
in future wound-healing studies. Cellular responses that
evolve in vivo over a chronic period are obviously very
complicated and multifactorial; however, tissue collection as
was performed in the Dalton study in this issue provides an
excellent sampling tool to open the window to our under-
standing of the perturbations that lead to skin breakdown.
In summary, Dalton et al have done a fine job of providing
the scientific community with a valuable characterization of
several major molecules that govern the state of the ECM
in skin exposed to chronic hypoxia. Although the ‘‘tissue
vulture strategy’’ in the wake of limb amputation is certainly
without glamor and glitz, this group has taken the scraps
from the biohazard waste and put forth information that
points toward the pathway of understanding that may one
day lead to advancements that make a difference. Events
that precede the development of skin ulceration are far from
settled.
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